Mylan Facing Antitrust Probe Over EpiPen's Market Power
Mylan NV confirmed Monday that it was under investigation by the Federal Trade Commission for practices related to sales of its EpiPen allergy emergency treatment, but said any suggestion the company...To view the full article, register now.
Already a subscriber? Click here to view full article